Oxford Finance Corporation

Oxford Finance Corporation is a financial services firm specializing in bespoke lending solutions for the life sciences and healthcare services sectors, facilitating growth through customized financial products. Founded in 2002 and headquartered in Alexandria, US, Oxford Finance Corporation focuses on providing innovative financial solutions. The firm was acquired by Wafra Capital in December 2016. Under the leadership of CEO J Philbrick, Oxford Finance has completed a total of 2 deals, with its latest funding round being a GROWTH round totaling USD 460.

00 mn, which raised the total amount to USD 460. 00 mn. Oxford Finance specializes in providing flexible and creative financial solutions primarily to companies within the life sciences and healthcare services sectors. The core offerings include bespoke loan solutions tailored for healthtech, life sciences, and SaaS borrowers, facilitating innovation from product development to commercial growth.

Additionally, the firm offers leveraged lending solutions that support companies and their investors throughout the transaction lifecycle, from closing to platform expansion and eventual exit. Oxford Finance serves a diverse clientele that includes over 700 companies globally, focusing on regions such as North America, Europe, and Asia. The company’s financing solutions are instrumental in addressing the unique capital needs of businesses aiming to drive innovation and growth in their respective industries. Oxford Finance has successfully originated more than USD 14 bn in loans since its inception, with credit facilities typically ranging from USD 5 mn to USD 200 mn.

The revenue structure is largely derived from interest income generated through various lending products, including term loans and revolving credit facilities. Transactions occur primarily through B2B arrangements, where healthcare companies engage Oxford Finance for capital to support their operational and growth initiatives. Clients may access tailored financing solutions that align with their specific business objectives, ensuring a partnership that emphasizes long-term success. Revenue generation is directly linked to the firm’s ability to provide customized financial solutions that meet the evolving needs of the healthcare sector, thereby reinforcing Oxford Finance's position as a trusted partner in this dynamic market.

Oxford Finance plans to leverage its latest GROWTH funding of USD 460. 00 mn to enhance its service offerings and expand its market reach. The company aims to introduce new financial products tailored for emerging life sciences technologies by the end of 2022 and explores opportunities for growth in Europe and Asia by establishing new offices in strategic locations. The recent acquisition by Wafra Capital is expected to support these initiatives and further solidify Oxford Finance's presence in the healthcare financing landscape.